Innodata Inc vs Relay Therapeutics Inc. Common Stock — how do they compare? Innodata Inc trades at $62.05 (market cap $2.18B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Innodata Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Innodata Inc for 19 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| INOD | RLAY | |
|---|---|---|
Market Cap | $2.18B | $3.94B |
Volume | 1,415,262 | 3,432,928 |
Sector | Technology | Health |
52-Week High | $121.50 | $20.75 |
52-Week Low | $34.45 | $6.03 |
Typical Hold Time | 19 Days | 0 Days |
Enterprise Value | $1.93B | $3.06B |
Signals from Pluang's Aura AI — not financial advice
INOD trades at $63.42, down 4.26% today, but maintains strong technical support near $63. The company demonstrates robust fundamentals with revenue growing from $252M in 2025 to $317M in 2026 and net income expanding from $32M to $46M. Recent quarterly earnings consistently beat expectations, with Q1 2026 EPS of $0.42 surpassing the $0.13 estimate. Analyst sentiment remains positive with a 66.7% buy rating consensus.
INOD presents growth potential through its AI data engineering services and new motion-capture lab expansion, though premium valuation metrics (P/E 49.12, P/S 6.91) and customer concentration risks warrant caution. The stock's technical positioning near key support levels combined with strong earnings momentum supports a constructive outlook for investors seeking AI infrastructure exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Innodata is a global data engineering company that provides solutions for training AI models. It helps enterprises solve complex data challenges through high-quality data annotation and digital transformation.
Read more on INOD →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →